Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2000-04-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM990315TPMID 10753465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and biological activity of new conformationally restricted analogues of pepstatin.

  2009cited by this paper
• A simple, continuous fluorometric assay for HIV protease.

  2009cited by this paper
• Protease inhibitors: current status and future prospects.

  2000cited by this paper
• Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease.

  1999cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Matrix metalloproteinases.

  1998cited by this paper
• Interaction of Secretory Leukocyte Protease Inhibitor with Heparin Inhibits Proteases Involved in Asthma*

  1998cited by this paper
• Towards protein surface mimetics.

  1998cited by this paper
• Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes.

  1998cited by this paper
• Structure of secreted aspartic proteinases from Candida. Implications for the design of antifungal agents.

  1998cited by this paper
• Cathepsin B and human tumor progression.

  1998cited by this paper
• Macrocyclic Inhibitors of Penicillopepsin. 2. X-ray Crystallographic Analyses of Penicillopepsin Complexed with a P3−P1 Macrocyclic Peptidyl Inhibitor and with Its Two Acyclic Analogues

  1998cited by this paper
• Macrocyclic amino carboxylates as selective MMP-8 inhibitors.

  1998cited by this paper
• Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-alpha production.

  1998cited by this paper
• Proteolytic degradation of host hemoglobin by schistosomes.

  1997cited by this paper
• Blunting Nature's Swiss Army Knife

  1997cited by this paper
• Assemblin, an essential herpesvirus proteinase.

  1997cited by this paper
• Meta-substituted benzofused macrocyclic lactams as zinc metalloprotease inhibitors.

  1997cited by this paper
• Cysteine Proteases and Their Inhibitors.

  1997cited by this paper
• Alzheimer's disease: genotypes, phenotypes, and treatments.

  1997cited by this paper
• IBC's 2nd International Conference on Protease Inhibitors: Novel Therapeutic Applications and Development, Washington DC, USA, 24-26 February 1997.

  1997cited by this paper
• Alzheimer's Disease--Genotypes, Phenotype, and Treatments

  1997cited by this paper
• The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site.

  1996cited by this paper
• Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

  1996cited by this paper
• Matrilysin-inhibitor complexes: common themes among metalloproteases.

  1996cited by this paper
• Protease inhibitors: novel therapeutic application and development.

  1996cited by this paper
• Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: Implications for the design of antifungal agents

  1996cited by this paper
• Three-dimensional structure of human cytomegalovirus protease

  1996cited by this paper
• Three-dimensional structure of human cytomegalovirus protease

  1996cited by this paper
• Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.

  1996cited by this paper
• Recent advances in matrix metalloproteinase inhibitor research

  1996cited by this paper
• Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 protease

  1996cited by this paper
• Substrate-based cyclic peptidomimetics of Phe-Ile-Val that inhibit HIV-1 protease using a novel enzyme-binding mode.

  1996cited by this paper
• Targeting HIV-1 protease: a test of drug-design methodologies.

  1995cited by this paper
• Mast cell tryptase: a new target for therapeutic intervention in asthma.

  1995cited by this paper
• Regioselective Structural and Functional Mimicry of Peptides - Design of Hydrolytically-Stable Cyclic Peptidomimetic Inhibitors of Hiv-1 Protease

  1995cited by this paper
• NMR solution structure of the RNA-binding peptide from human immunodeficiency virus (type 1) Rev.

  1995cited by this paper
• Cloning and Characterization of the Schistosoma japonicum Aspartic Proteinase Involved in Hemoglobin Degradation (*)

  1995cited by this paper
• Macrocyclic Peptidomimetics Forcing Peptides into Bioactive Conformations

  1995cited by this paper
• HIV protease as an inhibitor target for the treatment of AIDS.

  1994cited by this paper
• Inhibitors of human leukocyte elastase.

  1994cited by this paper
• Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.

  1994cited by this paper
• Design and synthesis of peptidomimetic inhibitors of HIV-1 protease and renin. Evidence for improved transport.

  1994cited by this paper
• Anti-malarial drug development using models of enzyme structure.

  1994cited by this paper
• Atomic structure of the trypsin-A90720A complex: a unified approach to structure and function.

  1994cited by this paper
• Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry.

  1994cited by this paper
• A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica

  1994cited by this paper
• Atomic Structure of the Trypsin-Cyclotheonamide a Complex: Lessons for the Design of Serine Protease Inhibitors

  1993cited by this paper
• A player of many parts: the spotlight falls on thrombin's structure.

  1993cited by this paper
• Structure-based inhibitors of HIV-1 protease.

  1993cited by this paper
• Design, synthesis, and crystal structure of a pyrrolinone-based peptidomimetic possessing the conformation of a .beta.-strand: potential application to the design of novel inhibitors of proteolytic enzymes

  1992cited by this paper
• Complex between the subtilisin from a mesophilic bacterium and the leech inhibitor eglin-C.

  1991cited by this paper
• A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base.

  1991cited by this paper
• Structures of complexes of rhizopuspepsin with pepstatin and other statine‐containing inhibitors

  1991cited by this paper
• Theory of protein secondary structure and algorithm of its prediction

  1983cited by this paper
• Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features

  1983cited by this paper
• The anatomy and taxonomy of protein structure.

  1981cited by this paper
• Binding of flexible ligands to macromolecules

  1975cited by this paper
• Determination of the helix and beta form of proteins in aqueous solution by circular dichroism.

  1974cited by this paper

• OBIMAP (One-Bead Interchain Multipeptide Assembly Platform).

  2026cites this paper
• Peptide inhibitors: Breaking cancer code.

  2025cites this paper
• Affinity selection–mass spectrometry with linearizable macrocyclic peptide libraries

  2025cites this paper
• AAontology: An ontology of amino acid scales for interpretable machine learning

  2024cites this paper
• How Polyproline Type II Conformation at P2 Residues Influences the Success of Proline-Based Peptidyl Inhibitors Against Coronavirus Main Protease.

  2024cites this paper
• A Strategy to Select Macrocyclic Peptides Featuring Asymmetric Molecular Scaffolds as Cyclization Units by Phage Display

  2022cites this paper
• Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptake

  2022cites this paper
• Overcoming Cellular and Systemic Barriers to Design the Next Wave of Peptide Therapeutics

  2021cites this paper
• Molecular enantiodiscrimination by NMR spectroscopy in chiral oriented systems: Concept, tools, and applications.

  2021cites this paper
• 2-Cyanoisonicotinamide Conjugation: A Facile Approach to Generate Potent Peptide Inhibitors of the Zika Virus Protease.

  2021cites this paper
• MOrPH-PhD: A Phage Display System for the Functional Selection of Genetically Encoded Macrocyclic Peptides.

  2021cites this paper
• Macrocycle Cell Permeability Measured by Solvation Free Energies in Polar and Apolar Environments

  2020cites this paper
• Quantitative structure-activity relationship (QSAR) models and their applicability domain analysis on HIV-1 protease inhibitors by machine learning methods

  2020cites this paper
• MOrPH-PhD: An Integrated Phage Display Platform for the Discovery of Functional Genetically Encoded Peptide Macrocycles

  2020cites this paper
• Macrocyclization via C-H functionalization: a new paradigm in macrocycle synthesis.

  2020cites this paper
• Anion recognition using a simple cyclic peptide

  2020cites this paper
• A biocompatible stapling reaction for in situ generation of constrained peptides

  2020cites this paper
• Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.

  2020cites this paper
• Expanded toolbox for directing the biosynthesis of macrocyclic peptides in bacterial cells† †Electronic supplementary information (ESI) available: Detailed experimental procedures, synthetic procedures, additional MS spectra and LC-MS chromatograms, NMR spectra. See DOI: 10.1039/d0sc01699c

  2020cites this paper
• Protein conformational transitions coupling with ligand interactions: Simulations from molecules to medicine

  2019cites this paper
• Photoredox Ni-catalyzed peptide C(sp2)–O cross-coupling: from intermolecular reactions to side chain-to-tail macrocyclization

  2019cites this paper
• Crystal Structures of Protein-Bound Cyclic Peptides.

  2019cites this paper
• An unexpected switch in peptide binding mode: from simulation to substrate specificity

  2018cites this paper
• Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins.

  2018cites this paper
• The use of residual dipolar couplings for conformational analysis of non-steroidal anti-inflammatory drugs dissolved in weakly ordering media

  2018cites this paper
• Activity of human kallikrein-related peptidase 6 (KLK6) on substrates containing sequences of basic amino acids. Is it a processing protease?

  2017cites this paper
• Impact of Cα‐Chirality on Supramolecular Self‐Assembly in Cyclo‐2:1‐[α/aza]‐Hexamers (d/l‐Phe‐azaPhe‐Ala)2

  2017cites this paper
• Versatility of Prolyl Oligopeptidase B in Peptide Macrocyclization.

  2017cites this paper
• Membrane Dynamics of γ-Secretase Provides a Molecular Basis for β-Amyloid Binding and Processing.

  2017cites this paper
• Biological and Hybrid Biological/Chemical Strategies in Diversity Generation of Peptidic Macrocycles

  2017cites this paper
• Investigating the impact of MpAPr1, an aspartic protease from the yeast Metschnikowia pulcherrima, on wine properties

  2017cites this paper
• Macrocycles for protein–protein interactions

  2017cites this paper
• Membrane Dynamics of γ-Secretase Provides a Molecular Basis for β-Amyloid Binding and Processing.

  2017cites this paper
• Macrocyclic Organo‐Peptide Hybrids by Intein‐Mediated Ligation: Synthesis and Applications

  2017cites this paper
• Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure

  2016cites this paper
• Side-chain-to-tail cyclization of ribosomally derived peptides promoted by aryl and alkyl amino-functionalized unnatural amino acids.

  2016cites this paper
• Structure-based design and synthesis of triazole-based macrocyclic inhibitors of norovirus protease: Structural, biochemical, spectroscopic, and antiviral studies

  2016cites this paper
• Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis

  2016cites this paper
• Spontaneous head-to-tail cyclization of unprotected linear peptides with the KAHA ligation† †Electronic supplementary information (ESI) available: Experimental procedures and analytical data of all new compounds. See DOI: 10.1039/c5sc01774b Click here for additional data file.

  2015cites this paper
• Fighting malaria: structure-guided discovery of nonpeptidomimetic plasmepsin inhibitors.

  2015cites this paper
• Proteases: nature’s destroyers and the drugs that stop them

  2015cites this paper
• Conformational features of 4-(N)-squalenoyl-gemcitabine in solution: a combined NMR and molecular dynamics investigation

  2015cites this paper
• Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino Acids.

  2015cites this paper
• Synthesis of macrocyclic organo-peptide hybrids from ribosomal polypeptide precursors via CuAAC-/hydrazide-mediated cyclization.

  2015cites this paper
• Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.

  2015cites this paper
• Efficient and Selective Palladium-Catalysed C-3 Urea Couplings to 3,5-Dichloro-2(1H)-pyrazinones

  2015cites this paper
• Design and Synthesis of Hepatitis C Virus NS3 Protease Inhibitors : Targeting Different Genotypes and Drug-Resistant Variants

  2015cites this paper
• Constraining cyclic peptides to mimic protein structure motifs.

  2014cites this paper
• Fixierung cyclischer Peptide: Mimetika von Proteinstrukturmotiven

  2014cites this paper
• Microbial aspartic proteases: current and potential applications in industry

  2014cites this paper
• Synthesis of bicyclic organo-peptide hybrids via oxime/intein-mediated macrocyclization followed by disulfide bond formation.

  2014cites this paper
• Conformational investigation in solution of a fluorinated anti-inflammatory drug by NMR spectroscopy in weakly ordering media.

  2014cites this paper
• Characterization of HCV Protease Inhibitors : Inhibition and Interaction Studies with Applications for Drug Discovery

  2013cites this paper
• Synthesis, 2D-NMR and molecular modelling studies of pentacycloundecane lactam-peptides and peptoids as potential HIV-1 wild type C-SA protease inhibitors

  2013cites this paper
• Macrocyclization of Organo‐Peptide Hybrids through a Dual Bio‐orthogonal Ligation: Insights from Structure–Reactivity Studies

  2013cites this paper
• Prediction and Analysis of Post-Translational Pyruvoyl Residue Modification Sites from Internal Serines in Proteins

  2013cites this paper
• Macrocycles as Templates for Diversity Generation in Drug Discovery

  2013cites this paper
• Emerging strategies to access peptide macrocycles from genetically encoded polypeptides.

  2013cites this paper
• Expression and purification of recombinant extracellular proteases originating from non-Saccharomyces yeasts

  2013cites this paper
• Truncated and Helix-Constrained Peptides with High Affinity and Specificity for the cFos Coiled-Coil of AP-1

  2013cites this paper
• Discovery of selective small molecular TACE inhibitors for the treatment of rheumatoid arthritis.

  2012cites this paper
• Prediction of Protein Cleavage Site with Feature Selection by Random Forest

  2012cites this paper
• Substituted imidazo[1,2-a]pyridines as β-strand peptidomimetics.

  2012cites this paper
• New Tripeptide‐Based Macrocyclic Calpain Inhibitors Formed by N‐Alkylation of Histidine

  2012cites this paper
• Chromogranin A-derived peptides are involved in innate immunity.

  2012cites this paper
• Internally quenched fluorescent peptide libraries with randomized sequences designed to detect endopeptidases.

  2012cites this paper
• Multi‐targeted activity of maslinic acid as an antimalarial natural compound

  2011cites this paper
• Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability

  2011cites this paper
• Molecular modeling: a search for a calpain inhibitor as a new treatment for cataractogenesis.

  2011cites this paper
• Modular assembly of macrocyclic organo-peptide hybrids using synthetic and genetically encoded precursors.

  2011cites this paper
• Bioinformatic Approaches for Predicting substrates of Proteases

  2011cites this paper
• Recent Advances in β‐Strand Mimetics

  2011cites this paper
• Synthesis of Novel Inhibitors of IdeS, a Bacterial Cysteine Protease Including Studies of Stereoselective Reductive Aminations

  2011cites this paper
• Discovery of amino acid motifs for thrombin cleavage and validation using a model substrate.

  2011cites this paper
• Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease.

  2011cites this paper
• Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery.

  2011cites this paper
• Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approach.

  2011cites this paper
• Mammalian Peptide Hormones: Biosynthesis and Inhibition

  2010cites this paper
• Update 1 of: Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure.

  2010cites this paper
• Molecular Dynamics Simulations Show That Conformational Selection Governs the Binding Preferences of Imatinib for Several Tyrosine Kinases*

  2010cites this paper
• Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinones.

  2010cites this paper
• Molecular Modelling for Enzyme Inhibition: A Search for a New Treatment for Cataract and New Antimicrobials and Herbicides

  2010cites this paper
• Connectivity and binding‐site recognition: Applications relevant to drug design

  2010cites this paper
• Update 1 of: Beta-strand mimetics.

  2010cites this paper
• Noncovalent tripeptidyl benzyl- and cyclohexyl-amine inhibitors of the cysteine protease caspase-1.

  2010cites this paper
• Synthesis and conformational analysis of bicyclic extended dipeptide surrogates.

  2010cites this paper
• Update 1 of: Proteases universally recognize beta strands in their active sites.

  2010cites this paper
• Structure-activity relationships for substrate-based inhibitors of human complement factor B.

  2009cites this paper
• Stabilising peptides of a sequential epitope of the Measles Virus Haemagglutinin protein and the implications for antigenicity and immunogenicity

  2009cites this paper
• The folding free-energy surface of HIV-1 protease: insights into the thermodynamic basis for resistance to inhibitors.

  2009cites this paper
• Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.

  2008cites this paper
• Quantitative measurement of protease ligand conformation

  2008cites this paper
• West Nile Virus NS2B/NS3 protease as an antiviral target.

  2008cites this paper
• β-Strand mimetics: formation of bend-strands in oligomers of enantiomeric β-amino acids

  2008cites this paper
• Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Aβ1–40 fibrillogenesis

  2008cites this paper
• Synthesis of Substituted 2‐Amino‐cyclobutanones

  2008cites this paper
• Crystal structures of highly constrained substrate and hydrolysis products bound to HIV-1 protease. Implications for the catalytic mechanism.

  2008cites this paper
• Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase

  2007cites this paper
• Identification of Potential Small Molecule Peptidomimetics Similar to Motifs in Proteins

  2007cites this paper
• Amyloid peptides and proteins in review.

  2007cites this paper